Pharming Group NV Cash Flow Reinvestment Rate
Pharming Group NV cash flow reinvestment rate. Pharming Group NV (PHARM) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting €93.00K (capex €70.00K plus investments €23.00K) from operating cash flow of €32.03 Million. Explore how well can Pharming Group NV service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Pharming Group NV (2017–2022)
Cash flow reinvestment rate of Pharming Group NV from 2017 to 2022. Historical reinvestment intensity for Pharming Group NV across 6 annual periods. Explore PHARM capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Pharming Group NV Cash Flow Reinvestment Rate by Year (2017–2022)
Pharming Group NV cash flow reinvestment rate by year from 2017 to 2022. Year-by-year capital reinvestment analysis for Pharming Group NV. For the full cash flow conversion analysis, see PHARM cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.41x | €9.28 Million | €22.90 Million | €1.98 Million | ▼ -28.8% |
| 2021 | 0.57x | €20.55 Million | €36.13 Million | €15.96 Million | ▲ +208.0% |
| 2020 | 0.18x | €16.80 Million | €90.98 Million | €16.47 Million | ▼ -51.3% |
| 2019 | 0.38x | €28.25 Million | €74.56 Million | €25.44 Million | ▲ +145.9% |
| 2018 | 0.15x | €7.12 Million | €46.19 Million | €4.31 Million | ▼ -27.6% |
| 2017 | 0.21x | €9.76 Million | €45.84 Million | €7.25 Million | — |